Results 71 to 80 of about 230,556 (169)
Exploring tear fluid biomarkers and the ocular surface in thyroid eye disease
Acta Ophthalmologica, Volume 104, Issue 1, Page e28-e38, February 2026.Abstract Purpose To examine ocular surface changes and inflammatory tear fluid biomarkers in patients with thyroid eye disease (TED). Methods We included 106 Graves' disease (GD) patients (36 without TED, 32 with active and 38 with inactive TED) and 106 age‐ and sex‐matched healthy subjects for ophthalmological evaluation, including ocular surface ...
Mikael Thomassen Neset +13 more
wiley +1 more source
Frequencies of alleles and genotypes in Graves' patients with and without orbitopathy.
, 2014 Frequencies of alleles and genotypes in Graves' patients with and without orbitopathy.
Tomasz Bednarczuk (236555) +10 more
core +1 more source
Single‐Cell RNA Sequencing of Thyroid Tissues Reveals Pathogenesis of Graves' Disease
Advanced Science, Volume 13, Issue 1, 5 January 2026.Using single‐cell RNA sequencing and TCR profiling, this study constructed an immune cell atlas in thyroid tissue of Graves’ disease (GD), revealing dominant IFN‐γ‐secreting CD4+ T cells, expanded Tph and CD11c+ B cells, and enriched T/NK cells. Notably, GD thyroid follicular cells (TFCs) activated γδ T cells, which recruited cDC1 cells, suggesting a ...
Xiaoyi Zhou +18 more
wiley +1 more source
Alemtuzumab-induced thyroid eye disease successfully treated with a single low dose of rituximab
European Thyroid JournalIntroduction: Secondary thyroid autoimmunity, especially Graves’ disease (GD), frequently develops in patients with multiple sclerosis (MS) following alemtuzumab treatment (ALTZ; anti-CD52). Thyroid eye disease (TED) can also develop, and rituximab (RTX;
Ilaria Muller +10 more
doaj +1 more source
Diabetes/Metabolism Research and Reviews, Volume 42, Issue 1, January 2026.ABSTRACT Timely diagnosis of type 1 diabetes (T1D), especially in high‐risk populations, is crucial for preventing serious health complications. T1D is a chronic progressive autoimmune disease that has presymptomatic stages that can be identified through the detection of islet autoantibodies. Given that T1D is associated with other autoimmune diseases,
Nick Thomas +8 more
wiley +1 more source
Advances in Public Health, Volume 2026, Issue 1, 2026.Purpose Thyroid eye disease (TED) is the most common orbital disorder in adults. Its initial clinical manifestations are heterogeneous and may influence early diagnosis and management. However, limited data exist on real‐world perspectives from oculoplastic surgeons who frequently manage patients with TED.
Shiqi Hui +4 more
wiley +1 more source
EMERGENCY TREATMENT OF GRAVES ORBITOPATHY
, 2011 GRAVES ORBITOPATHY EMERGENCY DEPARTMENT SUDDEN IMPAIRMENT ...
CARINI, Luisa +8 more
core
De-identified raw data for relationship between sociodemographic factors and Graves' orbitopathy
, 2018 Deidentified Raw Data for the research project "Relationship Between Sociodemographic Factors and Graves' Orbitopathy" separated into diagnosis based on ICD 9 codes.
Shortell, J (via Mendeley Data) +1 more
core +1 more source
Alemtuzumab‐Induced Graves’ Disease Complicated by Pretibial Myxoedema: A Case Report
Case Reports in Endocrinology, Volume 2026, Issue 1, 2026.Background Alemtuzumab, a monoclonal antibody targeting CD52, is associated with a high incidence of secondary autoimmune disease, most commonly thyroid dysfunction. Alemtuzumab‐induced Graves’ disease (AIGD) typically follows a relapsing course and may exhibit atypical or severe phenotypes during immune reconstitution (IR). Case Presentation We report
Aongus O’Brolchain +2 more
wiley +1 more source
RNFL Study in Graves Orbitopathy
, 2010 Purpose:to determine changes of retinal nerve fiber layer (RNFL) in a group of patients with serious thyroid-related immune orbitopathy and compare it with a group of patients with moderate Graves orbitopathy.
CAMPANERUT, SARA +4 more
core